Options
運用連線固相萃取-液相層析串聯質譜儀同時分析整體DNA甲基化與羥甲基化指標
Date Issued
2014
Author(s)
蔡依虹
Yi-Hung Tsai
Advisor
Abstract
本研究成功建立連線固相萃取-液相層析串聯質譜儀 (on-line SPE LC-MS/MS)搭配同位素稀釋法,可快速準確及同時分析DNA甲基化 (methylaion)和羥甲基化 (hydroxymethylaion)指標5-methyl-2’-deoxycytidine (5-mdC)及5-hydroxymethyl-2’-deoxycytidine (5-hmdC)。5-mdC與5-hmdC方法偵測極限,分別為0.054與0.132 fmol,總層析時間為15分鐘。本分析方法的組內變異 (intraday) 和組間變異 (interday) 之變異係數皆小於10 %,而5-mdC和5-hmdC的平均回收率為99-104 %。藉由5-mdC或5-hmdC與總cytidine之莫耳數比值 (分別為5-mdC/[5-mdC+5-hmdC+dC]和5-hmdC/[5-mdC+5-hmdC+dC]),可評估整體DNA甲基化或羥甲基化程度。小牛胸腺與大鼠肝臟DNA樣本甲基化程度分別為6.25 ± 0.11 %和3.31 ± 0.01 %;羥甲基化程度分別為0.0339 ± 0.0026 %和0.1387 ± 0.0063 %。本研究運用此分析方法同時分析尿液中可能經由細胞去甲基化機制所形成之DNA甲基化和羥甲基指標5-mdC和5-hmdC,並應用於30位健康成年人與6位肺癌患者的尿液樣本分析,結果發現在健康成年人尿液中5-mdC和5-hmdC分別為6.89 ± 4.92和3.68 ± 2.60 ng/mg creatinine;肺癌患者尿液中5-mdC和5-hmdC分別為13.54 ± 14.91和3.06 ± 1.53 ng/mg creatinine,本研究所建立之分析方法將來可運用於表觀遺傳學研究及大量臨床樣本檢測,以評估人體內整體DNA甲基化和羥甲基化程度。
A highly specific and sensitive liquid chromatography–tandem mass spectrometry method was first developed for simultaneously measuring 5-methyl-2’-deoxycytidine (5-mdC) and 5-hydroxymethyl-2’-deoxycytidine (5-hmdC) in DNA and urine. With the use of isotope internal standards (d3-5-mdC and d3-5-hmdC) and on-line solid-phase extraction, the detected limits of this method were 0.054 and 0.132 fmol on column for 5-mdC and 5-hmdC, respectively, and a total analysis time per sample as short as 15 min. Inter- and intraday imprecision was <10 % and the mean recovery of 5-mdC and 5-hmdC in DNA was 99-104 %. This method was then applied to evaluate the global DNA methylation and hydroxymethylaion levels in calf thymus and rat liver DNA. The global DNA methylation levels, based on the mole ratio of 5-mdC/(5-mdC+5-hmdC+dC), were found to be 6.25 ± 0.11 (%) and 3.31 ± 0.01 (%) for the calf thymus and rat liver DNA, respectively. The global DNA hydroxymethylation levels, based on the mole ratio of 5-hmdC/(5-mdC+5-hmdC+dC), were found to be 0.0339 ± 0.0026 (%) and 0.1387 ± 0.0063 (%) for the calf thymus and rat liver DNA, respectively.This method was further used to determine the levels of 5-mdC and 5-hmdC in human urine obtained from 30 healthy subjects and 6 lung cancer patients. The urinary levels of 5-mdC and 5-hmdC of healthy subjects were 6.89 ± 4.92 and 3.68 ± 2.60 ng/mg creatinine, respectively. The urinary levels of 5-mdC and 5-hmdC of lung cancer patients were 13.54 ± 14.91 and 3.06 ± 1.53 ng/mg creatinine, respectively. Overall, our newly developed on-line sample purification/enrichment system coupled with isotope-dilution LC-MS/MS method would be a useful tool for assessing global DNA methylation and hydroxymehtylation level in human.
Type
thesis
File(s)
No Thumbnail Available
Name
102CSMU5590003-001.zip
Size
2.23 MB
Format
Unknown
Checksum
(MD5):c89c2a4981aef300241838afef3a7c12